SCHEMBL6169817

SCHEMBL6169817

COC(=O)/C=C/c1ccc(C(F)(F)F)cc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CCR1 P32246 2/20 0.47
CCR2 P41597 2/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
ACLY P53396 3/20 0.46
KDM1A O60341 2/20 0.46
AVPR2 P30518 1/20 0.45
GPR27 Q9NS67 1/20 0.45
SNCA P37840 1/20 0.43
ERAP1 Q9NZ08 1/20 0.42
USP2 O75604 2/20 0.42
USP8 P40818 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
KAT6A Q92794 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169825 1.00 GAA (0.48) GAAMEN1KMT2ACCR1CCR2
SCHEMBL6169480 0.91 KDM1A (0.48) GAAMEN1KMT2ACCR1CCR2
SCHEMBL6169474 0.91 KDM1A (0.48) GAAMEN1KMT2ACCR1CCR2
SCHEMBL7482984 0.89 MEN1 (0.52) GAAMEN1KMT2ACCR1CCR2
SCHEMBL7482989 0.89 MEN1 (0.52) GAAMEN1KMT2ACCR1CCR2
SCHEMBL18046757 0.86 GAA (0.58) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL18046760 0.86 GAA (0.58) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL6169289 0.84 METAP2 (0.54) GAAMEN1KMT2ACCR2ALDH1A1
SCHEMBL6169283 0.84 METAP2 (0.54) GAAMEN1KMT2ACCR2ALDH1A1
SCHEMBL6173095 0.83 ERBB2 (0.52) GAAMEN1KMT2ACCR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1065206-B1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER (US) 2002-10-09 EP disclosed
EP-1065206-A1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER INC. (US) 2001-01-03 EP disclosed